Adverse drug reaction reporting via mobile applications: A narrative review.
Journal
International journal of medical informatics
ISSN: 1872-8243
Titre abrégé: Int J Med Inform
Pays: Ireland
ID NLM: 9711057
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
12
07
2022
revised:
01
10
2022
accepted:
07
10
2022
pubmed:
18
10
2022
medline:
11
11
2022
entrez:
17
10
2022
Statut:
ppublish
Résumé
Pharmacovigilance importance has increased in the last few decades and it has led to rise in awareness of adverse drug reaction reporting by both patients and health care professionals. Despite this, research shows reporting practice of health care professionals remains inadequate. Several educational and promotional activities were established in order to improve observed underreporting including the introduction of mobile applications that can be used to report adverse drug reactions. We aimed to review literature on adverse drug reaction reporting applications and whether their introduction improved reporting practice in patients and health care professionals. In this review, we have described several mobile application implementations in different countries. Moreover, we have illustrated some of the applications for particular patients, e.g. patients with multiple sclerosis. All of the included studies showed positive association between application use and ADR reporting. However, there is a great need for future high quality studies to confirm impact of mobile application on ADR reporting.
Identifiants
pubmed: 36252337
pii: S1386-5056(22)00209-X
doi: 10.1016/j.ijmedinf.2022.104895
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
104895Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.